Extendicare Stock Net Income
| EXETF Stock | USD 17.56 0.11 0.62% |
As of the 8th of February, Extendicare shows the Coefficient Of Variation of 324.91, downside deviation of 1.53, and Mean Deviation of 1.37. Extendicare technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices. Please confirm Extendicare variance, maximum drawdown, as well as the relationship between the Maximum Drawdown and semi variance to decide if Extendicare is priced favorably, providing market reflects its regular price of 17.56 per share. Given that Extendicare has jensen alpha of 0.6477, we urge you to verify Extendicare's prevailing market performance to make sure the company can sustain itself at a future point.
Extendicare's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Extendicare's valuation are provided below:Extendicare does not presently have any fundamental signals for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Extendicare |
Extendicare 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Extendicare's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Extendicare.
| 11/10/2025 |
| 02/08/2026 |
If you would invest 0.00 in Extendicare on November 10, 2025 and sell it all today you would earn a total of 0.00 from holding Extendicare or generate 0.0% return on investment in Extendicare over 90 days. Extendicare is related to or competes with Rhoen Klinikum, RHÖN-KLINIKUM Aktiengesellscha, WashTec AG, Life Healthcare, Panamera Holdings, Arjo AB, and Safilo Group. Extendicare Inc., through its subsidiaries, provides care and services for seniors in Canada More
Extendicare Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Extendicare's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Extendicare upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 1.53 | |||
| Information Ratio | 0.2662 | |||
| Maximum Drawdown | 16.03 | |||
| Value At Risk | (1.85) | |||
| Potential Upside | 3.04 |
Extendicare Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Extendicare's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Extendicare's standard deviation. In reality, there are many statistical measures that can use Extendicare historical prices to predict the future Extendicare's volatility.| Risk Adjusted Performance | 0.2543 | |||
| Jensen Alpha | 0.6477 | |||
| Total Risk Alpha | 0.4408 | |||
| Sortino Ratio | 0.3749 | |||
| Treynor Ratio | 8.18 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Extendicare's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Extendicare February 8, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.2543 | |||
| Market Risk Adjusted Performance | 8.19 | |||
| Mean Deviation | 1.37 | |||
| Semi Deviation | 0.7268 | |||
| Downside Deviation | 1.53 | |||
| Coefficient Of Variation | 324.91 | |||
| Standard Deviation | 2.16 | |||
| Variance | 4.66 | |||
| Information Ratio | 0.2662 | |||
| Jensen Alpha | 0.6477 | |||
| Total Risk Alpha | 0.4408 | |||
| Sortino Ratio | 0.3749 | |||
| Treynor Ratio | 8.18 | |||
| Maximum Drawdown | 16.03 | |||
| Value At Risk | (1.85) | |||
| Potential Upside | 3.04 | |||
| Downside Variance | 2.35 | |||
| Semi Variance | 0.5282 | |||
| Expected Short fall | (1.75) | |||
| Skewness | 2.53 | |||
| Kurtosis | 13.6 |
Extendicare Backtested Returns
Extendicare appears to be not too volatile, given 3 months investment horizon. Extendicare secures Sharpe Ratio (or Efficiency) of 0.32, which denotes the company had a 0.32 % return per unit of risk over the last 3 months. By reviewing Extendicare's technical indicators, you can evaluate if the expected return of 0.7% is justified by implied risk. Please utilize Extendicare's Coefficient Of Variation of 324.91, downside deviation of 1.53, and Mean Deviation of 1.37 to check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Extendicare holds a performance score of 25. The firm shows a Beta (market volatility) of 0.08, which means not very significant fluctuations relative to the market. As returns on the market increase, Extendicare's returns are expected to increase less than the market. However, during the bear market, the loss of holding Extendicare is expected to be smaller as well. Please check Extendicare's semi variance, and the relationship between the maximum drawdown and accumulation distribution , to make a quick decision on whether Extendicare's price patterns will revert.
Auto-correlation | 0.78 |
Good predictability
Extendicare has good predictability. Overlapping area represents the amount of predictability between Extendicare time series from 10th of November 2025 to 25th of December 2025 and 25th of December 2025 to 8th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Extendicare price movement. The serial correlation of 0.78 indicates that around 78.0% of current Extendicare price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.78 | |
| Spearman Rank Test | 0.85 | |
| Residual Average | 0.0 | |
| Price Variance | 0.59 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Extendicare reported net income of 11.5 M. This is 96.63% lower than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The net income for all United States stocks is 97.99% higher than that of the company.
Extendicare Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Extendicare's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Extendicare could also be used in its relative valuation, which is a method of valuing Extendicare by comparing valuation metrics of similar companies.Extendicare is currently under evaluation in net income category among its peers.
Extendicare Fundamentals
| Return On Equity | 0.0018 | |||
| Return On Asset | 0.11 | |||
| Profit Margin | 0.05 % | |||
| Operating Margin | 0.12 % | |||
| Current Valuation | 556.43 M | |||
| Shares Outstanding | 83.94 M | |||
| Shares Owned By Insiders | 13.15 % | |||
| Shares Owned By Institutions | 17.61 % | |||
| Price To Earning | 500.00 X | |||
| Price To Book | 4.28 X | |||
| Price To Sales | 0.32 X | |||
| Revenue | 1.22 B | |||
| Gross Profit | 283.88 M | |||
| EBITDA | 79.64 M | |||
| Net Income | 11.5 M | |||
| Cash And Equivalents | 174.61 M | |||
| Cash Per Share | 2.08 X | |||
| Total Debt | 463.27 M | |||
| Debt To Equity | 2.85 % | |||
| Current Ratio | 1.09 X | |||
| Book Value Per Share | 1.49 X | |||
| Cash Flow From Operations | 63.42 M | |||
| Earnings Per Share | 0.01 X | |||
| Number Of Employees | 31 | |||
| Beta | 1.2 | |||
| Market Capitalization | 419.69 M | |||
| Total Asset | 900.32 M | |||
| Z Score | 1.0 | |||
| Annual Yield | 0.07 % | |||
| Five Year Return | 6.60 % | |||
| Net Asset | 900.32 M | |||
| Last Dividend Paid | 0.48 |
About Extendicare Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Extendicare's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Extendicare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Extendicare based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Other Information on Investing in Extendicare Pink Sheet
Extendicare financial ratios help investors to determine whether Extendicare Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Extendicare with respect to the benefits of owning Extendicare security.